F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy

Trans R Soc Trop Med Hyg. 1998 Sep-Oct;92(5):572-3. doi: 10.1016/s0035-9203(98)90923-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antigens, Bacterial / blood*
  • Bacterial Proteins / blood*
  • Biomarkers / blood
  • Humans
  • Madagascar / epidemiology
  • Plague / diagnosis*
  • Plague / drug therapy
  • Prognosis
  • Streptomycin / therapeutic use
  • Sulfamethoxazole / therapeutic use
  • Trimethoprim / therapeutic use
  • Yersinia pestis / immunology*
  • Yersinia pestis / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Antigens, Bacterial
  • Bacterial Proteins
  • Biomarkers
  • caf1 protein, Yersinia pestis
  • Trimethoprim
  • Sulfamethoxazole
  • Streptomycin